Abbott Laboratories Stock Net Income
| ABL Stock | 92.77 0.82 0.89% |
As of the 3rd of February, Abbott Laboratories shows the risk adjusted performance of (0.08), and Mean Deviation of 1.05. Abbott Laboratories technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Abbott Laboratories Total Revenue |
|
Market Capitalization 210.4 B | Enterprise Value Revenue 4.405 |
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 15.4 B | 16.2 B | |
| Net Income | 15.4 B | 16.2 B |
Abbott | Net Income |
The evolution of Net Income for Abbott Laboratories provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Abbott Laboratories compares to historical norms and industry peers.
Latest Abbott Laboratories' Net Income Growth Pattern
Below is the plot of the Net Income of Abbott Laboratories over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Abbott Laboratories financial statement analysis. It represents the amount of money remaining after all of Abbott Laboratories operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Abbott Laboratories' Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Abbott Laboratories' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 13.4 B | 10 Years Trend |
|
Net Income |
| Timeline |
Abbott Net Income Regression Statistics
| Arithmetic Mean | 5,032,424,412 | |
| Geometric Mean | 3,064,170,086 | |
| Coefficient Of Variation | 103.33 | |
| Mean Deviation | 4,062,313,945 | |
| Median | 2,368,000,000 | |
| Standard Deviation | 5,200,249,491 | |
| Sample Variance | 27042594.8T | |
| Range | 15.7B | |
| R-Value | 0.85 | |
| Mean Square Error | 7842557.2T | |
| R-Squared | 0.73 | |
| Significance | 0.000013 | |
| Slope | 878,728,971 | |
| Total Sum of Squares | 432681516.4T |
Abbott Net Income History
Abbott Laboratories 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Abbott Laboratories' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Abbott Laboratories.
| 11/05/2025 |
| 02/03/2026 |
If you would invest 0.00 in Abbott Laboratories on November 5, 2025 and sell it all today you would earn a total of 0.00 from holding Abbott Laboratories or generate 0.0% return on investment in Abbott Laboratories over 90 days. Abbott Laboratories is related to or competes with NTG Nordic, Knight-Swift Transportation, Liberty Broadband, Train Alliance, Transport International, and NAKED WINES. Abbott Laboratories is entity of Germany More
Abbott Laboratories Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Abbott Laboratories' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Abbott Laboratories upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 14.56 | |||
| Value At Risk | (2.11) | |||
| Potential Upside | 1.91 |
Abbott Laboratories Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Abbott Laboratories' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Abbott Laboratories' standard deviation. In reality, there are many statistical measures that can use Abbott Laboratories historical prices to predict the future Abbott Laboratories' volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.35) | |||
| Treynor Ratio | 1.4 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Abbott Laboratories' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Abbott Laboratories February 3, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | 1.41 | |||
| Mean Deviation | 1.05 | |||
| Coefficient Of Variation | (806.92) | |||
| Standard Deviation | 1.8 | |||
| Variance | 3.24 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.35) | |||
| Treynor Ratio | 1.4 | |||
| Maximum Drawdown | 14.56 | |||
| Value At Risk | (2.11) | |||
| Potential Upside | 1.91 | |||
| Skewness | (2.77) | |||
| Kurtosis | 17.63 |
Abbott Laboratories Backtested Returns
Abbott Laboratories secures Sharpe Ratio (or Efficiency) of -0.13, which signifies that the company had a -0.13 % return per unit of standard deviation over the last 3 months. Abbott Laboratories exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Abbott Laboratories' risk adjusted performance of (0.08), and Mean Deviation of 1.05 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.17, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Abbott Laboratories are expected to decrease at a much lower rate. During the bear market, Abbott Laboratories is likely to outperform the market. At this point, Abbott Laboratories has a negative expected return of -0.24%. Please make sure to confirm Abbott Laboratories' coefficient of variation, value at risk, rate of daily change, as well as the relationship between the total risk alpha and kurtosis , to decide if Abbott Laboratories performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.62 |
Good predictability
Abbott Laboratories has good predictability. Overlapping area represents the amount of predictability between Abbott Laboratories time series from 5th of November 2025 to 20th of December 2025 and 20th of December 2025 to 3rd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Abbott Laboratories price movement. The serial correlation of 0.62 indicates that roughly 62.0% of current Abbott Laboratories price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.62 | |
| Spearman Rank Test | 0.11 | |
| Residual Average | 0.0 | |
| Price Variance | 51.34 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Abbott Net Interest Income
Net Interest Income |
|
Based on the recorded statements, Abbott Laboratories reported net income of 13.4 B. This is much higher than that of the Metals & Mining sector and significantly higher than that of the Materials industry. The net income for all Germany stocks is notably lower than that of the firm.
Abbott Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Abbott Laboratories' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Abbott Laboratories could also be used in its relative valuation, which is a method of valuing Abbott Laboratories by comparing valuation metrics of similar companies.Abbott Laboratories is currently under evaluation in net income category among its peers.
Abbott Laboratories ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Abbott Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Abbott Laboratories' managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Abbott Fundamentals
| Current Valuation | 163.2 B | |||
| Price To Book | 3.75 X | |||
| Price To Sales | 4.34 X | |||
| Revenue | 41.95 B | |||
| EBITDA | 10.69 B | |||
| Net Income | 13.4 B | |||
| Total Debt | 1.5 B | |||
| Cash Flow From Operations | 8.56 B | |||
| Price To Earnings To Growth | 4.14 X | |||
| Market Capitalization | 210.39 B | |||
| Total Asset | 81.41 B | |||
| Retained Earnings | 47.26 B | |||
| Working Capital | 9.5 B | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 81.41 B |
About Abbott Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Abbott Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abbott Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abbott Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Abbott Stock Analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.